KAYO MOTOR
834058
Zhejiang Zoenn Design
300901
Zhejiang Meorient Commerce & Exhibition Inc.
300795
Fujian Zitian Media Technology
300280
Zhejiang Prulde Electric Appliance
301353
CN Stock MarketDetailed Quotes
300086 Honz Pharmaceutical
- 6.08
- -0.12-1.94%
Market Closed Dec 13 15:00 CST
2.77BMarket Cap-30.55P/E (TTM)
6.37High6.05Low418.12KlotVolume6.17Open6.20Pre Close258.18MTurnover9.49%Turnover Ratio243.20P/E (Static)455.12MShares7.3052wk High2.21P/B2.68BFloat Cap3.3552wk Low7.44Limit Up440.79MShs Float35.50Historical High4.96Limit Down5.16%Amplitude3.35Historical Low--Dividend TTM6.17Avg Price217.39KlotAsk--Div YieldTTM100Lot Size194.29KlotBid
Honz Pharmaceutical Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -19.46%363.81M | -33.88%220.2M | -40.01%104.74M | 38.05%739.57M | 29.37%451.72M | 45.34%333.02M | 58.81%174.6M | -35.96%535.75M | -40.43%349.17M | -45.90%229.13M |
| Operating revenue | -19.46%363.81M | -33.88%220.2M | -40.01%104.74M | 38.05%739.57M | 29.37%451.72M | 45.34%333.02M | 58.81%174.6M | -35.96%535.75M | -40.43%349.17M | -45.90%229.13M |
| Other operating revenue | ---- | 16.66%13.71M | ---- | 15.36%36.47M | ---- | 29.19%11.75M | ---- | 6.90%31.61M | ---- | 4.87%9.1M |
| Total operating cost | 8.76%522.88M | 5.69%342.59M | -5.24%153.59M | 2.41%705.19M | 2.58%480.76M | 0.40%324.15M | 1.75%162.09M | -18.29%688.6M | -30.11%468.69M | -31.70%322.84M |
| Operating cost | -13.90%169.33M | -36.41%95.55M | -41.78%49.75M | 12.20%295.77M | 8.69%196.68M | 19.78%150.26M | 38.40%85.45M | -36.40%263.61M | -43.11%180.96M | -49.35%125.44M |
| Operating tax surcharges | -15.67%9.56M | -19.84%6.07M | -28.00%2.99M | 43.46%15.61M | 65.16%11.33M | 97.91%7.57M | 129.96%4.16M | -4.57%10.88M | 6.61%6.86M | -8.58%3.83M |
| Operating expense | 39.73%209.5M | 69.74%151.03M | 75.88%60.62M | -18.10%212.91M | -18.36%149.93M | -31.08%88.97M | -48.22%34.47M | -9.26%259.95M | -24.76%183.65M | -15.08%129.1M |
| Administration expense | 5.55%96.52M | 14.54%64.9M | 9.59%31.17M | 38.60%139.68M | 36.12%91.45M | 28.07%56.66M | 29.32%28.44M | 3.30%100.77M | -9.64%67.19M | -15.07%44.25M |
| Financial expense | -12.66%14.91M | -20.22%9.65M | -18.72%4.42M | -9.60%22.54M | -6.42%17.08M | -2.73%12.09M | 86.17%5.44M | 37.53%24.94M | 42.62%18.25M | 61.51%12.43M |
| -Interest expense (Financial expense) | -21.82%13.89M | -26.85%9.02M | -33.23%4.14M | -7.68%25.3M | -11.41%17.77M | -9.02%12.32M | 54.22%6.2M | 46.23%27.4M | 67.79%20.06M | 72.78%13.55M |
| -Interest Income (Financial expense) | 62.44%-692.6K | 58.70%-569.6K | 59.21%-328.49K | -2.03%-2.86M | 12.40%-1.84M | 11.26%-1.38M | 20.23%-805.24K | -122.19%-2.8M | -649.70%-2.11M | -34.90%-1.55M |
| Research and development | 61.23%23.05M | 79.19%15.39M | 12.21%4.64M | -34.32%18.68M | 21.36%14.3M | 10.16%8.59M | -2.98%4.14M | 93.42%28.44M | -20.64%11.78M | -13.49%7.8M |
| Credit Impairment Loss | -57.11%3.39M | -49.29%4.21M | -119.73%-1.18M | 62.81%-3.57M | 46.60%7.92M | 179.40%8.3M | 450.27%5.97M | 47.33%-9.61M | 227.57%5.4M | 326.99%2.97M |
| Asset Impairment Loss | -1,535.54%-10.12M | -50.99%-5.97M | 155.64%1.46M | 88.22%-4.51M | 116.78%704.69K | -78.91%-3.95M | -52.60%-2.62M | -130.73%-38.32M | -217.23%-4.2M | -57.27%-2.21M |
| Other net revenue | 24.90%18.5M | -36.40%5.73M | -77.94%1.21M | 84.48%-9.4M | 129.88%14.81M | 77.16%9M | 1,238.55%5.48M | -319.83%-60.56M | -87.72%6.44M | 31,665.31%5.08M |
| Fair value change income | ---- | ---- | ---- | 39.06%-11.6M | ---- | ---- | ---- | -660.76%-19.04M | ---- | ---- |
| Invest income | --16.85M | ---- | ---- | ---- | ---- | ---- | ---- | -100.38%-210.38K | -100.29%-160.75K | -119.65%-110.59K |
| -Including: Investment income associates | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 39.89%-210.38K | 43.85%-160.75K | 30.40%-110.59K |
| Asset deal income | -96.10%25.15K | -87.19%25.15K | ---- | 625.25%717.54K | 5,216.20%644.86K | 1,517.85%196.25K | -222.17%-14.82K | 47.35%98.94K | -81.93%12.13K | -80.19%12.13K |
| Other revenue | 50.55%8.35M | 67.30%7.46M | -56.68%929.33K | 46.94%9.57M | 2.90%5.55M | 0.91%4.46M | -44.73%2.15M | 100.19%6.51M | 105.47%5.39M | 111.32%4.42M |
| Operating profit | -887.59%-140.56M | -752.65%-116.66M | -364.73%-47.64M | 111.71%24.98M | 87.41%-14.23M | 120.17%17.87M | 136.77%18M | -1,097.82%-213.41M | -253.39%-113.08M | -80.47%-88.64M |
| Add:Non operating Income | 1,559.03%594.63K | 4,576.64%158.13K | 191.22%5.66K | -48.77%133.27K | -85.05%35.84K | -101.51%-3.53K | -102.66%-6.21K | 17.92%260.14K | 8.92%239.77K | 15.27%234.19K |
| Less:Non operating expense | 393.78%1.94M | 985.08%1.39M | 1,167.73%230.2K | -80.04%1.67M | -83.66%393.79K | -81.01%128.16K | -93.77%18.16K | 567.74%8.37M | 128.83%2.41M | -17.59%674.76K |
| Total profit | -872.61%-141.91M | -764.44%-117.89M | -366.34%-47.86M | 110.58%23.45M | 87.34%-14.59M | 119.92%17.74M | 136.68%17.97M | -1,188.30%-221.52M | -251.03%-115.25M | -79.12%-89.08M |
| Less:Income tax cost | -302.08%-17.26M | -622.35%-15.77M | -114.34%-529.9K | 177.56%18.28M | 410.35%8.54M | 353.56%3.02M | 320.72%3.7M | -340.88%-23.57M | -133.21%-2.75M | -88.89%665.5K |
| Net profit | -438.87%-124.65M | -793.57%-102.13M | -431.59%-47.33M | 102.61%5.17M | 79.44%-23.13M | 116.41%14.72M | 130.17%14.27M | -1,972.52%-197.95M | -173.58%-112.49M | -61.06%-89.74M |
| Net profit from continuing operation | -438.87%-124.65M | -793.57%-102.13M | -431.59%-47.33M | 102.61%5.17M | 79.44%-23.13M | 116.41%14.72M | 130.17%14.27M | -1,972.52%-197.95M | -173.58%-112.49M | -61.06%-89.74M |
| Less:Minority Profit | 28.32%-1.92M | 20.31%-1.26M | 27.26%-829.12K | 38.64%-6.36M | 7.09%-2.68M | 19.52%-1.59M | -5.41%-1.14M | -2,391.58%-10.37M | -692.04%-2.88M | -202.75%-1.97M |
| Net profit of parent company owners | -500.08%-122.73M | -718.36%-100.86M | -401.69%-46.5M | 106.15%11.53M | 81.34%-20.45M | 118.58%16.31M | 133.34%15.41M | -1,807.25%-187.58M | -163.45%-109.61M | -52.28%-87.77M |
| Earning per share | ||||||||||
| Basic earning per share | -494.05%-0.2697 | -719.06%-0.2241 | -401.17%-0.1033 | 106.14%0.0256 | 81.36%-0.0454 | 118.56%0.0362 | 133.37%0.0343 | -1,808.61%-0.4169 | -163.35%-0.2436 | -52.22%-0.195 |
| Diluted earning per share | -494.05%-0.2697 | -719.06%-0.2241 | -401.17%-0.1033 | 106.14%0.0256 | 81.36%-0.0454 | 118.56%0.0362 | 133.37%0.0343 | -1,808.61%-0.4169 | -163.35%-0.2436 | -52.22%-0.195 |
| Other composite income | -167.26%-484.82K | -137.98%-181.4K | ||||||||
| Other composite income of parent company owners | ---- | ---- | ---- | -167.26%-484.82K | ---- | ---- | ---- | -137.98%-181.4K | ---- | ---- |
| Total composite income | -438.87%-124.65M | -793.57%-102.13M | -431.59%-47.33M | 102.36%4.68M | 79.44%-23.13M | 116.41%14.72M | 130.17%14.27M | -1,893.22%-198.13M | -173.58%-112.49M | -61.06%-89.74M |
| Total composite income of parent company owners | -500.08%-122.73M | -718.36%-100.86M | -401.69%-46.5M | 105.88%11.05M | 81.34%-20.45M | 118.58%16.31M | 133.34%15.41M | -1,737.72%-187.77M | -163.45%-109.61M | -52.28%-87.77M |
| Total composite income of minority owners | 28.32%-1.92M | 20.31%-1.26M | 27.26%-829.12K | 38.64%-6.36M | 7.09%-2.68M | 19.52%-1.59M | -5.41%-1.14M | -2,391.58%-10.37M | -692.04%-2.88M | -202.75%-1.97M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | China Audit Zhonghuan Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- | -- | China Audit Zhonghuan Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
